CAT No: CP26398
CAS No:14609-04-2
Synonyms/Alias:Boc-Lys(Nicotinoyl)-OH;14609-04-2;AC1Q1MSJ;SCHEMBL5970365;Boc-N-Epsilon-nicotinoyl-L-lysine;ZINC2555035;6410AH;AKOS015909227;I14-33660;N2-(TERT-BUTOXYCARBONYL)-N6-(PYRIDIN-3-YLCARBONYL)-L-LYSINE;Boc-Lys(Nicotinoyl)-OH;(S)-2-((tert-Butoxycarbonyl)amino)-6-(nicotinamido)hexanoic acid;(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-6-(pyridine-3-carbonylamino)hexanoic acid;Na-Boc-Ne-nicotinoyl-L-lysine;Boc-N-Epsilon-nicotinoyl-L-lysine;SCHEMBL5970365;AKOS015909227;AS-46828;F10640;(S)-2-(tert-butoxycarbonylamino)-6-(nicotinamido)hexanoic acid;L-Lysine,n2-[(1,1-dimethylethoxy)carbonyl]-n6-(3-pyridinylcarbonyl)-;(2S)-2-[(tert-Butoxycarbonyl)amino]-6-[(3-pyridinylcarbonyl)amino]hexanoic acid
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.